"Haifong Biomedical" Edoxaban correction solution group - Taiwan Registration f04f8a1ae4e9e7e5d9cd0cdd67f9ca74
Access comprehensive regulatory information for "Haifong Biomedical" Edoxaban correction solution group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f04f8a1ae4e9e7e5d9cd0cdd67f9ca74 and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is lyophilized human plasma doped with different concentrations of Edoxaban for correction of Edoxaban measurement.
A Clinical chemistry and clinical toxicology
A.1150 Calibrated Products
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Jun 15, 2021
Jun 15, 2026

